Announcements Trials
Browse Landscape

Phase

Phase 3 3Phase NA 1Phase 1/2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 5Prostatic Neoplasms 4Osteoporosis 3Pain 2Neoplasms 2Neoplasm Metastasis 2Multiple Myeloma 1Hypercalcemia 1Humoral Hypercalcemia Of Malignancy 1Carcinoma, Ductal, Breast 1Breast Neoplasms, Male 1Breast Cancer Metastatic 1Bone Diseases, Metabolic 1

Interventions

Zoledronic Acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Humoral Hypercalcemia Of Malignancy × Zoledronic Acid × Clear all
NCT00458796 2022-05-27

Comparison of Two Schedules of Zoledronic Acid in Treating Patients With Breast Cancer That Has Spread to the Bone

University of Leeds

Phase NA Terminated
1,500 enrolled
Breast

Humoral Hypercalcemia Of Malignancy, Breast Neoplasms, Neoplasm Metastasis, Pain, Breast Neoplasms, Male

Data powered by HemOnc (CC BY 4.0) Colophon âš¡